ARDX
NASDAQ · Biotechnology
Ardelyx Inc
$6.19
+0.01 (+0.16%)
Open$6.28
Previous Close$6.18
Day High$6.38
Day Low$6.15
52W High$8.40
52W Low$3.49
Volume—
Avg Volume3.83M
Market Cap1.49B
P/E Ratio—
EPS$-0.24
SectorBiotechnology
Analyst Ratings
Strong Buy
17 analysts
Price Target
+661.6% upside
Current
$6.19
$6.19
Target
$47.14
$47.14
$33.22
$47.14 avg
$55.45
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 430.26M | 216.86M | 556.78M |
| Net Income | -65,076,883 | -29,520,763 | -22,621,785 |
| Profit Margin | -15.1% | -14.4% | -4.1% |
| EBITDA | -40,049,271 | -19,176,818 | -31,484,723 |
| Free Cash Flow | — | — | -21,445,059 |
| Rev Growth | +98.4% | +98.4% | +16.2% |
| Debt/Equity | 1.21 | 1.21 | 0.37 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $243.73 | +3.76% | 105.2 | 382.49B |
| AMGN | Amgen Inc | $356.32 | +1.39% | 23.4 | 182.21B |
| GILD | Gilead Sciences Inc | $124.43 | -0.58% | 16.7 | 153.66B |
| VRTX | Vertex Pharmaceuticals Inc | $484.49 | +1.96% | 26.4 | 114.63B |
| REGN | Regeneron Pharmaceuticals | $625.11 | +0.27% | 14.5 | 63.95B |
| ALNY | Alnylam Pharmaceuticals Inc | $291.90 | -0.73% | 64.3 | 37.13B |